Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Kunlin Li (Chongqing, China), Kun-lin Li, Jun Kang, Li Li, Yu-bo Wang, Yong He. Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion. Eur Respir J 2015; 46: Suppl. 59, 5004

Member's Comments

No comment yet.

Related content which might interest you: The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Survival of non small cell lung carcinoma patients with malignant pleural effusions Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training Year: 2014 What outcome after pleurodesis in malignant pleural effusion in lung cancer? Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor? Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Recruitment and phenotypic characteristics of interleukin 9−Producing CD4+ T cells in malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Cetuximab administered through pulmonary route in a mice model of lung tumor Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Lung adenocarcinoma mimicking interstitial lung disease showed good response to navelbine monotherapy Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016